Myosana Therapeutics Finds $1M In Funding
socalTECH
APRIL 22, 2020
Newport Beach-based Myosana Therapeutics , a biotech company which is working on technology for non-viral gene delivery, has raised $1M in its seed funding round, the company said this morning. The funding came from CureDuchenne Ventures. The company said the new funding will go towards development of its non-viral gene therapy, for delivering a treatment for Duchenne muscular dystrophy (DMD).
Let's personalize your content